Effects of anthocyanins on cardiovascular risk factors and inflammation in pre-hypertensive men: a double-blind randomized placebo-controlled crossover study

Posted at — Mario Hernández Cueto — enero 25th, 2013 — 12:06 under factores de riesgo

Effects of anthocyanins on cardiovascular risk factors and inflammation in pre-hypertensive men: a double-blind randomized placebo-controlled crossover study

2-riesgo-cardiovascularPor:  S S Hassellund, S E Kjeldsen, I Seljeflot, A Karlsen y I Erlund y M Rostrup.  Journal of Human Hypertension (2013) 27, 100–106.

High intake of fruits and vegetables is associated with reduced cardiovascular risk. A number of fruits and vegetables are rich in anthocyanins, which constitute a subgroup of the flavonoids. Anthocyanins have demonstrated anti-inflammatory and anti-oxidative properties, and anthocyanin-rich interventions have indicated beneficial effects on blood pressure and other cardiovascular risk factors. We assessed whether a purified anthocyanin supplement improves cardiovascular metabolic risk factors and markers of inflammation and oxidative stress in prehypertensive participants, and whether plasma polyphenols are increased following intake. [publicada: 25 enero de 2013

———————————————————–

Treatment of hypertension in the elderly: data from an international cohort of hypertensives treated by cardiologists

Por: M Thoenes, D Spirk, M Böhm, F Mahfoud, L Thevathasan y P Bramlage.  Journal of Human Hypertension (2013) 27, 131–137.

Hypertension in the elderly is a major risk factor for cardiovascular disease. We aimed to analyze determinants of blood pressure (BP) control across different age groups. Population of a large global survey on hypertension treatment and control including 18 927 patients was analyzed. A logistic regression analysis was conducted to estimate BP control rates and the prevalence of antihypertensive drug usage according to age. Systolic BP control decreased from 29.6% (95% confidence intervals (CI) 26.0;33.5) at 18–40 years to 22.4% (20.8;24.2) at >75 years (P<0.0001), and diastolic BP control increased from 31.6% (27.9;35.6) to 57.3% (55.2;59.3), respectively (P<0.0001). [publicada: 25 de enero 2013]

No responses yet